Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop-Reference-Cited by-同舟云学术

Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

Published:2018-03-25 Issue:4 Volume:31 Page:343-352
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Rickels Michael R.¹^ORCID,Stock Peter G.²,de Koning Eelco J. P.³,Piemonti Lorenzo⁴^ORCID,Pratschke Johann⁵,Alejandro Rodolfo⁶,Bellin Melena D.⁷,Berney Thierry⁸^ORCID,Choudhary Pratik⁹,Johnson Paul R.¹⁰,Kandaswamy Raja¹¹,Kay Thomas W. H.¹²,Keymeulen Bart¹³,Kudva Yogish C.¹⁴,Latres Esther¹⁵,Langer Robert M.¹⁶,Lehmann Roger¹⁷,Ludwig Barbara¹⁸,Markmann James F.¹⁹,Marinac Marjana¹⁵,Odorico Jon S.²⁰,Pattou François²¹,Senior Peter A.²²,Shaw James A. M.²³,Vantyghem Marie-Christine²⁴,White Steven²³

Affiliation:

1. Department of Medicine; Division of Endocrinology, Diabetes & Metabolism; Institute for Diabetes, Obesity & Metabolism; Perelman School of Medicine; University of Pennsylvania; Philadelphia PA USA

2. Department of Surgery; Division of Transplantation; University of California at San Francisco; San Francisco CA USA

3. Department of Medicine; Leiden University Medical Center; Leiden The Netherlands

4. Diabetes Research Institute; San Raffaele Scientific Institute; Milan Italy

5. Department of Surgery; Charité Medical School; Berlin Germany

6. Department of Medicine; Division of Endocrinology, Diabetes & Metabolism; Diabetes Research Institute; University of Miami Miller School of Medicine; Miami FL USA

7. Department of Pediatrics; Division of Endocrinology; Schulze Diabetes Institute; University of Minnesota; Minneapolis MN USA

8. Department of Surgery; Division of Transplantation and Visceral Surgery; Geneva University Hospital; Geneva Switzerland

9. Diabetes Research Group; King's College London; London UK

10. Nuffield Department of Surgical Sciences; University of Oxford; Oxford UK

11. Department of Surgery; Division of Transplantation; Schulze Diabetes Institute; University of Minnesota; Minneapolis MN USA

12. Department of Medicine; St. Vincent's Hospital; St. Vincent's Institute of Medical Research; University of Melbourne; Melbourne Vic. Australia

13. Diabetes Research Center; Vrije Universiteit Brussel; Brussels Belgium

14. Department of Internal Medicine; Division of Endocrinology, Diabetes, Metabolism & Nutrition; Mayo Clinic; Rochester MN USA

15. JDRF International; New York NY USA

16. Ordensklinikum Elisabethinin Hospital; Linz Austria

17. Department of Endocrinology and Diabetology; University Hospital Zurich; Zurich Switzerland

18. Department of Medicine III; Division of Endocrinology and Diabetes; University Hospital Carl Gustav Carus at the Technische Universität Dresden; Dresden Germany

19. Department of Surgery; Division of Transplantation; Massachusetts General Hospital; Boston MA USA

20. Department of Surgery; Division of Transplantation; University of Wisconsin School of Medicine and Public Health; Madison WI USA

21. Department of General and Endocrine Surgery; Centre Hospitalier Universitaire de Lille; Inserm; Université de Lille; Lille France

22. Department of Medicine; Division of Endocrinology & Metabolism; University of Alberta; Edmonton AB Canada

23. Institute of Transplantation; The Freeman Hospital; Newcastle University; Newcastle upon Tyne UK

24. Department of Endocrinology, Diabetology and Metabolism; Centre Hospitalier Universitaire de Lille; Inserm; Université de Lille; Lille France

Funder

Juvenile Diabetes Research Foundation International

National Institute of Diabetes and Digestive and Kidney Diseases

The Transplantation Society

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.13138/fullpdf

Reference29 articles.

1. Report from IPITA-TTS opinion leaders meeting on the future of beta-cell replacement;Bartlett;Transplantation,2016

2. Executive summary of the IPITA-TTS opinion leaders meeting on the future of beta-cell replacement;Markmann;Transplantation,2016

3. Standardizing clinically meaningful outcome measures beyond HbA1c for type 1 diabetes;Agiostratidou;Diabetes Care,2017

4. Outcome measures for artificial pancreas clinical trials: a consensus report;Maahs;Diabetes Care,2016

5. Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes;International Hypoglycemia Study Group;Diabetes Care,2017

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Whole Pancreas and Islet Cell Transplantation;Textbook of Diabetes;2024-01-12

2. Donor noradrenaline use is associated with better allograft survival in recipients of pancreas transplantation;The Annals of The Royal College of Surgeons of England;2024-01

3. Medical and Surgical Management of the Failed Pancreas Transplant;Transplantation Direct;2023-12-12

4. Encapsulated stem cell–derived β cells exert glucose control in patients with type 1 diabetes;Nature Biotechnology;2023-11-27

5. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge;Frontiers in Immunology;2023-11-23